← Research library

Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes

Animal research · 2023

What was studied
Mouse pharmacology experiments
Main finding
The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.

Study data at a glance

Participants or experimental model
Mouse pharmacology experiments
Reported results
The camphane chlorobenzamide candidate increased treadmill performance by 23.22–25.20% after 14 days of administration. Baseline group differences complicate interpretation; the text describes convergence toward control running times. Complexation of Chlodantane, Bromantane and ADK-918 neutralized their actoprotective effects in the tested preparations; the new derivatives were classified as moderately toxic.
Study limitations and source details

Study limitations

  • Abstract-level animal findings do not establish human performance benefits or improved clinical safety.
  • An effect at a 14-day assessment does not prove a benefit persisted for 14 days after one dose.
  • The Russian and English versions are one publication, not independent replication.

Source details

Institute abstract and selected author-uploaded full-text passages checked, including the 7/14-day schedule and baseline-imbalance discussion; complete tables not independently appraised.

Sources checked

Citation

Animal / experimentalFull text available

A. A. Vernigora, R. V. Brunilin, O. V. Vostrikova, et al.. Comparative Evaluation of the Pharmacological Activity of Fatty Aromatic Amides and Amines with a Framework Moiety and Their Non-Covalent Complexes Pharmaceutical Chemistry Journal. 57(4):523–534

Study source ↗ · DOI 10.1007/s11094-023-02915-z · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards